SofWave Medical Management
Management criteria checks 3/4
SofWave Medical's CEO is Louis Scafuri, appointed in Jul 2019, has a tenure of 5.83 years. total yearly compensation is $981.00K, comprised of 60.3% salary and 39.7% bonuses, including company stock and options. directly owns 0.061% of the company’s shares, worth ₪449.17K. The average tenure of the management team and the board of directors is 2.5 years and 5.7 years respectively.
Key information
Louis Scafuri
Chief executive officer
US$981.0k
Total compensation
| CEO salary percentage | 60.35% |
| CEO tenure | 5.8yrs |
| CEO ownership | 0.06% |
| Management average tenure | 2.5yrs |
| Board average tenure | 5.7yrs |
Recent management updates
Recent updates
Take Care Before Jumping Onto SofWave Medical Ltd. (TLV:SOFW) Even Though It's 26% Cheaper
Apr 08
Companies Like SofWave Medical (TLV:SOFW) Can Afford To Invest In Growth
Jan 17Investors Aren't Entirely Convinced By SofWave Medical Ltd.'s (TLV:SOFW) Revenues
Nov 15We Think Some Shareholders May Hesitate To Increase SofWave Medical Ltd.'s (TLV:SOFW) CEO Compensation
Sep 11SofWave Medical Ltd. (TLV:SOFW) Screens Well But There Might Be A Catch
May 02Even With A 27% Surge, Cautious Investors Are Not Rewarding SofWave Medical Ltd.'s (TLV:SOFW) Performance Completely
Jan 31A Piece Of The Puzzle Missing From SofWave Medical Ltd.'s (TLV:SOFW) 31% Share Price Climb
Nov 17We're Not Worried About SofWave Medical's (TLV:SOFW) Cash Burn
Nov 13Here's Why We're Not Too Worried About SofWave Medical's (TLV:SOFW) Cash Burn Situation
May 05Here's Why We're Not Too Worried About SofWave Medical's (TLV:SOFW) Cash Burn Situation
Dec 22Is SofWave Medical (TLV:SOFW) In A Good Position To Invest In Growth?
Aug 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -US$5m |
| Dec 31 2024 | US$981k | US$592k | -US$5m |
| Sep 30 2024 | n/a | n/a | -US$4m |
| Jun 30 2024 | n/a | n/a | -US$4m |
| Mar 31 2024 | n/a | n/a | -US$5m |
| Dec 31 2023 | US$1m | US$547k | -US$8m |
| Sep 30 2023 | n/a | n/a | -US$12m |
| Jun 30 2023 | n/a | n/a | -US$15m |
| Mar 31 2023 | n/a | n/a | -US$18m |
| Dec 31 2022 | US$837k | US$508k | -US$20m |
Compensation vs Market: Louis's total compensation ($USD981.00K) is above average for companies of similar size in the IL market ($USD668.88K).
Compensation vs Earnings: Louis's compensation has been consistent with company performance over the past year.
CEO
Louis Scafuri (72 yo)
Mr. Louis Scafuri serves as the Chief Executive Officer at SofWave Medical Ltd.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 5.8yrs | US$981.00k | 0.061% ₪ 449.2k | |
| Co-Founder & CTO | 10.3yrs | US$336.00k | 9.45% ₪ 69.6m | |
| Chief Financial Officer | 3.7yrs | US$1.27m | 0.73% ₪ 5.4m | |
| COO & Site Manager | no data | US$392.00k | no data | |
| Chief Digital Officer | 1.3yrs | US$583.00k | no data | |
| Co-Founder & Chairman | 10.3yrs | no data | 24.22% ₪ 178.2m | |
| Chief Medical Officer | 6.3yrs | US$310.00k | no data | |
| Chief Innovation Officer | 1.3yrs | no data | no data | |
| Executive VP of North American Sales | less than a year | no data | no data | |
| Chief Commercial Officer | less than a year | no data | no data | |
| Vice President of Quality | no data | no data | no data |
Experienced Management: SOFW's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman | 10.3yrs | no data | 24.22% ₪ 178.2m | |
| Independent Outside Director | 4yrs | no data | 0.0068% ₪ 50.0k | |
| Independent Director | 6.3yrs | no data | 1.03% ₪ 7.6m | |
| External Director | 3.8yrs | no data | no data | |
| External Director | 3.8yrs | no data | no data | |
| Director | 5.8yrs | no data | no data | |
| Director | 5.7yrs | no data | 0.11% ₪ 783.4k |
Experienced Board: SOFW's board of directors are considered experienced (5.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/28 17:33 |
| End of Day Share Price | 2025/05/28 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SofWave Medical Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.